Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial – PACHA-01 (NCT02494973)
Diane Goèré(Assistance Publique – Hôpitaux de Paris), David Malka(Inserm), Thierry de Baère(Institut Gustave Roussy), Maximiliano Gelli(Université Paris-Saclay), Valérie Boige(Inserm), Jean‐Pierre Pignon(Inserm), Michel Ducreux(Université Paris-Saclay), Frédèric Deschamps(Institut Gustave Roussy), Léonor Benhaïm(Institut Gustave Roussy), Dominique Elias(Institut Gustave Roussy), Caroline Caramella(Institut Gustave Roussy)
Cited by 46
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
|Journal of Clinical Oncology|2011|2.1k
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2010|1.9k
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
|Journal of Clinical Oncology|2006|1.7k
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.3k